openPR Logo
Press release

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market US$ 3.5 Billion by 2021

09-29-2017 07:41 AM CET | Health & Medicine

Press release from: iHealthcareAnalyst, Inc.

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market

The global idiopathic pulmonary fibrosis treatment market expected to reach US$ 3.5 billion by 2021, growing at CAGR 14.4% over the forecast period 2017-2021, owing to increasing drug prices and rapid approval of new treatments.

Visit Idiopathic Pulmonary Fibrosis (IPF) Treatment Market by Treatment Type - Pharmacological Treatment (Pirfenidone (Esbriet), Nintedanib (Ofev), Generic Pirfenidone); Non-pharmacological Treatment (Oxygen Therapy, Pulmonary Rehabilitation, Mechanical Ventilation, Lung Transplantation, Other Non-Pharmacological Treatment); Patients by Disease Severity (Mild, Moderate, Severe); Drug Pipeline Analysis (AEOL-10150, Lebrikizumab, Tipelukast, Tralokinumab, FG-3019, Simtuzumab, BMS-986020, AF-219, SAR156597, BG00011, PRM-151, PBI-4050)
and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/idiopathic-pulmonary-fibrosis-treatment-market/

The global idiopathic pulmonary fibrosis treatment market research report provides market size (Revenue USD Million 2014 to 2021), patient numbers by disease severity and by country (U.S., Japan, U.K. Germany, France, Italy, Spain, 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global idiopathic pulmonary fibrosis treatment market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global idiopathic pulmonary fibrosis treatment market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries.

The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments. Major players operating in the global idiopathic pulmonary fibrosis treatment market and profiled in this report include Aeolus Pharmaceuticals, Baxter International, Biogen, Inc., Boehringer Ingelheim, F. Hoffmann-La Roche, FibroGen, Inc., Gilead Sciences, Inventiva Pharma, MediciNova, Inc., Merck & Co. (Afferent Pharmaceuticals, Inc.), Promedior, Inc., Prometheus Laboratories, Inc., and Shionogi & Company.

1. Treatment Type
1.1. Pharmacological Treatment - Drug (Brand)
1.1.1. Pirfenidone (Esbriet)
1.1.2. Nintedanib (Ofev)
1.1.3. Generic Pirfenidone
1.2. Non-pharmacological Treatment
1.2.1. Oxygen Therapy
1.2.2. Pulmonary Rehabilitation
1.2.3. Mechanical Ventilation
1.2.4. Lung Transplantation
1.2.5. Other Non-Pharmacological Treatment

2. Patients (Disease Severity)
2.1. Mild
2.2. Moderate
2.3. Severe

3. Pipeline Analysis
3.1. AEOL-10150
3.2. Lebrikizumab
3.3. Tipelukast
3.4. Tralokinumab
3.5. FG-3019
3.6. Simtuzumab
3.7. BMS-986020
3.8. AF-219
3.9. SAR156597
3.10. BG00011
3.11. PRM-151
3.12. PBI-4050

4. Geography
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC
4.5. Rest of the World

5. Company Profiles
5.1. Aeolus Pharmaceuticals
5.2. Baxter International
5.3. Biogen, Inc.
5.4. Boehringer Ingelheim
5.5. F. Hoffmann-La Roche
5.6. FibroGen, Inc.
5.7. Gilead Sciences
5.8. Inventiva Pharma
5.9. MediciNova, Inc.
5.10. Merck & Co. (Afferent Pharmaceuticals, Inc.)
5.11. Promedior, Inc.
5.12. Prometheus Laboratories, Inc.
5.13. Shionogi & Company

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/idiopathic-pulmonary-fibrosis-treatment-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market US$ 3.5 Billion by 2021 here

News-ID: 747193 • Views: 454

More Releases from iHealthcareAnalyst, Inc.

Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/ The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by
Global Cerebrospinal Fluid Management Market to Reach 1.9 US$ billion by 2023 gr …
According to a new market research report (updated 2018) published by iHealthcareAnalyst, Inc., Cerebrospinal Fluid Management Market – Global CSF Products Analysis and Forecast 2018-2023, the global cerebrospinal fluid management market was valued at US$ 1,045 Million in 2013 and to reach US$ 1.9 billion by 2023, growing at a CAGR of 5.5% from 2018-2023. Visit the Global Cerebrospinal Fluid Management Market – Global Patient Solutions, System Strengthening and End Users

All 5 Releases


More Releases for Treatment

WASTEWATER TREATMENT
What if we are all part of the solution and not part of the pollution, what if we lived in a world that is less polluted because the amount of waste generated are properly treated before disposal, what if we had clean and clear water made available for everyone? These and many what ifs we can ask ourselves.Billions of tonnes of waste are been produced annually with about 42 million
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Rotator Cuff Tendinopathy Treatment
If you are suffering from rotator cuff tendinopathy, the tendon collagen in the rotator cuff of the shoulder has degenerated. This degeneration can cause chronic weakness, pain, limited range of motion and inflammation. While the breakdown of collagen can’t be reversed, the progression and symptoms of the condition can be managed through a combination of modalities. DIAGNOSIS Before treatment, you need an orthopedic doctor to diagnose the condition. Your doctor would begin by
Deep Wrinkle FOld Treatment
Feel that you look older than your age? Your face always seems to be having a sad look? These are mainly due to deep wrinkles and folds that develop over time on our face due to ageing of the bone, muscle, ligaments and fat loss on our face. Nasolabial Fold: (Nose to lip corner) Some lines in this area are natural, but as they get deeper, the skin folds over and makes the face
Vitamin Deficiency Treatment Market
Undernourishment in the underdeveloped countries is the major driver of growth of global vitamin deficiency treatment market. High incidence of anemia, paraesthesia and other hypovitaminosis are the other major factors contributing to hike in global vitamin deficiency treatment market. Vitamin supplements are also used as an adjunct therapy in many disorders including alopecia, depression, ulcers etc., high prevalence of which can propel the growth of global vitamin deficiency treatment market.
Global Sinusitis Treatment Market
Factors contributing for growth of sinusitis treatment market are demand for diagnostic test and antibiotics, patient education programs by companies and hospitals for increasing awareness among the public. Advancement in technology, myriad of people suffering from common cold and no age specific are additional factors that will drive the market over the forecasted period. Though the sinusitis treatment market is expected to generate significant revenue throughout the forecast period, the